S&P 500   3,948.72
DOW   32,105.25
QQQ   309.75
Why Wall Street Loves These 3 Penny Stocks
Bank Accounts: Frozen! (Ad)
3 Leading Dividend Stocks Expected To Grow Earnings
Chewy Stock Is Setting Up For Long-Term Profitable Growth 
Bank Accounts: Frozen! (Ad)
Closing prices for crude oil, gold and other commodities
Low Volume Bunge Plunge Presents an Opportunity
My No. 1 dividend stock for a LIFETIME of income. (Ad)
KB Home Strong Results Lift Prices
Carvana May Be Able To Reach Profitability This Year
S&P 500   3,948.72
DOW   32,105.25
QQQ   309.75
Why Wall Street Loves These 3 Penny Stocks
Bank Accounts: Frozen! (Ad)
3 Leading Dividend Stocks Expected To Grow Earnings
Chewy Stock Is Setting Up For Long-Term Profitable Growth 
Bank Accounts: Frozen! (Ad)
Closing prices for crude oil, gold and other commodities
Low Volume Bunge Plunge Presents an Opportunity
My No. 1 dividend stock for a LIFETIME of income. (Ad)
KB Home Strong Results Lift Prices
Carvana May Be Able To Reach Profitability This Year
S&P 500   3,948.72
DOW   32,105.25
QQQ   309.75
Why Wall Street Loves These 3 Penny Stocks
Bank Accounts: Frozen! (Ad)
3 Leading Dividend Stocks Expected To Grow Earnings
Chewy Stock Is Setting Up For Long-Term Profitable Growth 
Bank Accounts: Frozen! (Ad)
Closing prices for crude oil, gold and other commodities
Low Volume Bunge Plunge Presents an Opportunity
My No. 1 dividend stock for a LIFETIME of income. (Ad)
KB Home Strong Results Lift Prices
Carvana May Be Able To Reach Profitability This Year
S&P 500   3,948.72
DOW   32,105.25
QQQ   309.75
Why Wall Street Loves These 3 Penny Stocks
Bank Accounts: Frozen! (Ad)
3 Leading Dividend Stocks Expected To Grow Earnings
Chewy Stock Is Setting Up For Long-Term Profitable Growth 
Bank Accounts: Frozen! (Ad)
Closing prices for crude oil, gold and other commodities
Low Volume Bunge Plunge Presents an Opportunity
My No. 1 dividend stock for a LIFETIME of income. (Ad)
KB Home Strong Results Lift Prices
Carvana May Be Able To Reach Profitability This Year
NYSE:USPH

U.S. Physical Therapy - USPH Stock Forecast, Price & News

$91.96
-1.23 (-1.32%)
(As of 03/23/2023 12:00 AM ET)
Add
Compare
Today's Range
$91.12
$94.05
50-Day Range
$89.65
$103.58
52-Week Range
$73.30
$131.50
Volume
77,783 shs
Average Volume
90,630 shs
Market Capitalization
$1.20 billion
P/E Ratio
40.87
Dividend Yield
1.87%
Price Target
$110.00

U.S. Physical Therapy MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
19.6% Upside
$110.00 Price Target
Short Interest
Bearish
5.55% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.09mentions of U.S. Physical Therapy in the last 14 days
Based on 5 Articles This Week
Insider Trading
Selling Shares
$484,853 Sold Last Quarter
Proj. Earnings Growth
20.61%
From $2.62 to $3.16 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.35 out of 5 stars

Medical Sector

236th out of 989 stocks

Health Services Industry

4th out of 12 stocks


USPH stock logo

About U.S. Physical Therapy (NYSE:USPH) Stock

U.S. Physical Therapy, Inc. operates outpatient physical therapy clinics, which provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries. It operates through the following segments: physical therapy operations and industrial injury prevention services. The physical therapy operations segment consist of physical therapy and occupational therapy clinics that provide pre-and postoperative care and treatment for orthopedic related disorders, sports-related injuries, preventive care, rehabilitation of injured workers and neurological injuries. The injury prevention services segment includes onsite injury prevention and rehabilitation, performance optimization and ergonomic assessments. U.S. The company was founded in 1990 and is headquartered in Houston, TX.

Receive USPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for U.S. Physical Therapy and its competitors with MarketBeat's FREE daily newsletter.

USPH Stock News Headlines

U.S. Physical Therapy Inc.
Fed's Shocking New Plan to Control Your Money
The Federal Reserve has a disturbing plan that is getting ready to roll out as soon as May. This is a lot more than printing trillions of dollars or manipulating interest rates. It's about every checking account, every purchase and every money transfer in America — including yours and mine. 
Fed's Shocking New Plan to Control Your Money
The Federal Reserve has a disturbing plan that is getting ready to roll out as soon as May. This is a lot more than printing trillions of dollars or manipulating interest rates. It's about every checking account, every purchase and every money transfer in America — including yours and mine. 
What Can Physical Therapy Do for You?
Should You Hold U.S. Physical Therapy (USPH)?
Massive Insider Trade At US Physical Therapy
See More Headlines
Receive USPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for U.S. Physical Therapy and its competitors with MarketBeat's FREE daily newsletter.

USPH Company Calendar

Last Earnings
11/04/2021
Ex-Dividend for 4/7 Dividend
3/09/2023
Today
3/23/2023
Dividend Payable
4/07/2023
Next Earnings (Estimated)
5/04/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Health services
Sub-Industry
Health Care Facilities
Sector
Medical
CUSIP
90337L10
Employees
6,135
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$110.00
High Stock Price Forecast
$110.00
Low Stock Price Forecast
$110.00
Forecasted Upside/Downside
+19.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$32.16 million
Pretax Margin
10.05%

Debt

Sales & Book Value

Annual Sales
$553.14 million
Cash Flow
$4.36 per share
Book Value
$24.39 per share

Miscellaneous

Free Float
12,781,000
Market Cap
$1.20 billion
Optionable
Optionable
Beta
1.34

Key Executives

  • Christopher J. ReadingChristopher J. Reading
    President, Chief Executive Officer & Director
  • Eric Joseph Williams
    Chief Operating Officer
  • Carey P. Hendrickson
    Chief Financial & Accounting Officer
  • Chadd Pence
    Vice President-Information Systems
  • Jayne Fleck Pool
    Chief Compliance Officer & VP-Clinical Services













USPH Stock - Frequently Asked Questions

Should I buy or sell U.S. Physical Therapy stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for U.S. Physical Therapy in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" USPH shares.
View USPH analyst ratings
or view top-rated stocks.

What is U.S. Physical Therapy's stock price forecast for 2023?

1 Wall Street research analysts have issued twelve-month price objectives for U.S. Physical Therapy's shares. Their USPH share price forecasts range from $110.00 to $110.00. On average, they expect the company's share price to reach $110.00 in the next year. This suggests a possible upside of 19.6% from the stock's current price.
View analysts price targets for USPH
or view top-rated stocks among Wall Street analysts.

How have USPH shares performed in 2023?

U.S. Physical Therapy's stock was trading at $81.03 at the beginning of the year. Since then, USPH stock has increased by 13.5% and is now trading at $91.95.
View the best growth stocks for 2023 here
.

When is U.S. Physical Therapy's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 4th 2023.
View our USPH earnings forecast
.

How were U.S. Physical Therapy's earnings last quarter?

U.S. Physical Therapy, Inc. (NYSE:USPH) announced its earnings results on Thursday, November, 4th. The company reported $0.85 EPS for the quarter, topping analysts' consensus estimates of $0.78 by $0.07. The business earned $125.90 million during the quarter, compared to the consensus estimate of $124.67 million. U.S. Physical Therapy had a trailing twelve-month return on equity of 11.29% and a net margin of 5.81%. U.S. Physical Therapy's quarterly revenue was up 15.6% compared to the same quarter last year. During the same quarter last year, the business earned $0.86 EPS.

How often does U.S. Physical Therapy pay dividends? What is the dividend yield for U.S. Physical Therapy?

U.S. Physical Therapy declared a quarterly dividend on Thursday, February 23rd. Investors of record on Friday, March 10th will be given a dividend of $0.43 per share on Friday, April 7th. This represents a $1.72 dividend on an annualized basis and a yield of 1.87%. The ex-dividend date of this dividend is Thursday, March 9th. This is a boost from the stock's previous quarterly dividend of $0.41.
Read our dividend analysis for USPH
.

Is U.S. Physical Therapy a good dividend stock?

U.S. Physical Therapy (NYSE:USPH) pays an annual dividend of $1.72 per share and currently has a dividend yield of 1.80%. The company has been increasing its dividend for 4 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio is 76.44%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, USPH will have a dividend payout ratio of 54.43% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for USPH.

What is Chris Reading's approval rating as U.S. Physical Therapy's CEO?

38 employees have rated U.S. Physical Therapy Chief Executive Officer Chris Reading on Glassdoor.com. Chris Reading has an approval rating of 49% among the company's employees. This puts Chris Reading in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of U.S. Physical Therapy own?

Based on aggregate information from My MarketBeat watchlists, some companies that other U.S. Physical Therapy investors own include Pfizer (PFE), NVIDIA (NVDA), AbbVie (ABBV), CVS Health (CVS), Gilead Sciences (GILD), International Business Machines (IBM), Illumina (ILMN), Johnson & Johnson (JNJ), Lowe's Companies (LOW) and Marathon Petroleum (MPC).

What is U.S. Physical Therapy's stock symbol?

U.S. Physical Therapy trades on the New York Stock Exchange (NYSE) under the ticker symbol "USPH."

Who are U.S. Physical Therapy's major shareholders?

U.S. Physical Therapy's stock is owned by a number of retail and institutional investors. Top institutional shareholders include T. Rowe Price Investment Management Inc. (7.04%), Morgan Stanley (5.40%), Copeland Capital Management LLC (4.64%), Boston Trust Walden Corp (4.07%), Riverbridge Partners LLC (3.09%) and Dimensional Fund Advisors LP (2.80%). Insiders that own company stock include Anne Motsenbocker, Bernard A Harris Jr, Bernard A Harris, Jr, Carey P Hendrickson, Christopher J Reading, Christopher J Reading, Clayton Trier, Edward L Kuntz, Eric Joseph Williams, Glenn Mcdowell, Graham D Reeve, Graham D Reeve, Harry S Chapman, Harry S Chapman, Kathleen A Gilmartin, Lawrance W Mcafee, Mark J Brookner and Richard Binstein.
View institutional ownership trends
.

How do I buy shares of U.S. Physical Therapy?

Shares of USPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is U.S. Physical Therapy's stock price today?

One share of USPH stock can currently be purchased for approximately $91.95.

How much money does U.S. Physical Therapy make?

U.S. Physical Therapy (NYSE:USPH) has a market capitalization of $1.20 billion and generates $553.14 million in revenue each year. The company earns $32.16 million in net income (profit) each year or $2.25 on an earnings per share basis.

How many employees does U.S. Physical Therapy have?

The company employs 6,135 workers across the globe.

How can I contact U.S. Physical Therapy?

U.S. Physical Therapy's mailing address is 1300 WEST SAM HOUSTON PARKWAY SUITE 300, HOUSTON TX, 77042. The official website for the company is www.usph.com. The company can be reached via phone at (713) 297-7000, via email at lmcafee@usph.com, or via fax at 713-297-7090.

This page (NYSE:USPH) was last updated on 3/24/2023 by MarketBeat.com Staff